FIRM FIXED PRICENO SET ASIDE USED.

AVKARE LLC - NEW AWARD FOR VARDENAFIL HCL TABLETS WITH AVKARE. PERFORMANCE PERIOD IS AUGUST 7, 2022 - AUGUST 6, 2023 WITH FOUR ONE-YEAR OPTIONS

PIID: 36E79722D0015Solicitation ID: 36E79722D0015
Signed Date: Dec 16, 2025Effective Date: Aug 7, 2022
Vendor
AVKARE LLC
NAICS
325412
Signed Date
Dec 16, 2025

Key Details

Dollars Obligated
Base & All Options
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
3

Description

NEW AWARD FOR VARDENAFIL HCL TABLETS WITH AVKARE. PERFORMANCE PERIOD IS AUGUST 7, 2022 - AUGUST 6, 2023 WITH FOUR ONE-YEAR OPTIONS

Context & Analysis

On Dec 16, 2025, Department of Veterans Affairs to AVKARE LLC for new award for vardenafil hcl tablets with avkare. performance period is august 7, 2022 - august 6, 2023 with four one-year options. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside.

Contractor Information

Contractor: AVKARE LLC
UEI: SFPGXE6XPS93
CAGE Code: 4QGW8
Location: PULASKI, TN

Stay Updated

Get notified about new opportunities matching your interests.

Related